MEDICAL DEVICE CLINICAL TRIALS

Medical Device News Magazine brings healthcare professionals, researchers, medical device executives, investors, and industry leaders timely coverage of the latest medical device clinical trials, clinical research studies, emerging scientific data, and technological developments shaping the future of medicine and healthcare.

Our coverage follows medical technologies throughout the clinical development process—from early feasibility and first-in-human studies to pivotal clinical trials, long-term follow-up studies, post-market research, and real-world evidence. Readers can stay informed about new devices and technologies being evaluated across a broad range of medical specialties, including cardiovascular care, vascular medicine, orthopedics, surgery, medical imaging, diagnostics, oncology, neurology, digital health, robotic-assisted surgery, and other rapidly evolving areas of healthcare.

Medical Device News Magazine also reports on important clinical trial results and regulatory milestones, including significant study endpoints, patient outcomes, safety and efficacy findings, FDA submissions, approvals and clearances, and other developments that may influence the commercialization and adoption of new medical technologies.

Beyond reporting study results, our coverage examines the broader significance of medical device research. We highlight innovations that have the potential to improve patient outcomes, provide physicians with new treatment options, reduce procedural complexity, advance minimally invasive care, improve diagnostic accuracy, and address unmet clinical needs.

As medical technology continues to advance at an extraordinary pace, clinical evidence has become increasingly important to physicians, healthcare organizations, regulators, manufacturers, investors, and other decision-makers. Understanding the research behind emerging technologies can provide valuable insight into which innovations may ultimately influence clinical practice and reshape standards of care.

With comprehensive reporting, industry perspectives, and coverage of important scientific and regulatory developments, Medical Device News Magazine helps readers understand not only what is happening in medical device clinical research, but also why it matters.

Whether you are a physician evaluating emerging treatment options, a researcher following new clinical evidence, a medical device executive monitoring industry developments, or an investor assessing the next generation of healthcare technologies, Medical Device News Magazine provides the timely information and insights you need to stay informed in an increasingly innovative and rapidly evolving industry.

Stoke Therapeutics Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndrome at the American Epilepsy Society 2023 Annual Meeting

Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modificatio. Analysis of 72 patients treated in STK-001 clinical trials suggests that higher STK-001 drug exposure in brain leads to greater seizure reductions. Two-year data from the longest prospective natural history study of Dravet syndrome showed that, on average, patients experienced no meaningful improvement in convulsive seizure frequency and exhibited widening gaps in cognition and behavior despite treatment with the best available anti-seizure medicines.